February 01, 2011 at 15:41 PM EST
Pfizer Joins Other Pharmas in Giving a Cautious Outlook
Pfizer reported fourth-quarter earnings on Tuesday that nearly quadrupled from a year ago as revenue rose 6%. But it also lowered its sales guidance for 2012, due to some of its bestselling drugs going off patent. What's ahead for the world's biggest drugmaker: Continue reading Pfizer Joins Other Pharmas in Giving a Cautious Outlook Pfizer Joins Other Pharmas in Giving a Cautious Outlook originally appeared on DailyFinance on Tue, 01 Feb 2011 15:41:00. Filed Under: Company News , Health Care , Earnings , Pfizer , Bristol-Myers Squibb , Novartis , Eli Lilly , Astrazeneca Permalink | Tweet this! | Comments
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here